Closure of Percutaneous Vascular Access

Chapter

Abstract

A variety of contemporary closure technologies expand the strategies available to the endovascular interventionalist for vascular access management. The currently available devices have consistently demonstrated the ability to shorten time to hemostasis and ambulation; decrease in access-site-related bleeding complications has not yet been convincingly shown. Careful observation of users’ instructions of individual devices and operators’ expertise in their use are likely the most critical determinants of clinical success in on-label indications. Further studies are needed to define clinical benefits in specific subsets and to clarify the cost-effectiveness of VCDs in real-life settings.

Keywords

Peripheral Arterial Disease Manual Compression Arterial Puncture Balloon Aortic Valvuloplasty Vascular Closure Device 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Biancari F, D’Andrea V, Di Marco C, Savino G, Tiozzo V, Catania A (2010) Meta-analysis of randomized trials on the efficacy of vascular closure devices after diagnostic angiography and angioplasty. Am Heart J 159:518–531PubMedCrossRefGoogle Scholar
  2. 2.
    Koreny M, Riedmuller E, Nikfardjam M, Siostrzonek P, Mullner M (2004) Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis. JAMA 291:350–357PubMedCrossRefGoogle Scholar
  3. 3.
    Juergens CP, Leung DY, Crozier JA et al (2004) Patient tolerance and resource utilization associated with an arterial closure versus an external compression device after percutaneous coronary intervention. Catheter Cardiovasc Interv 63:166–170PubMedCrossRefGoogle Scholar
  4. 4.
    Marso SP, Amin AP, House JA et al (2010) Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention. JAMA 303:2156–2164PubMedCrossRefGoogle Scholar
  5. 5.
    Camenzind E, Grossholz M, Urban P, Dorsaz PA, Didier D, Meier B (1994) Collagen application versus manual compression: a prospective randomized trial for arterial puncture site closure after coronary angioplasty. J Am Coll Cardiol 24:655–662PubMedCrossRefGoogle Scholar
  6. 6.
    Carey D, Martin JR, Moore CA, Valentine MC, Nygaard TW (2001) Complications of femoral artery closure devices. Catheter Cardiovasc Interv 52:3–7; discussion 8PubMedCrossRefGoogle Scholar
  7. 7.
    Chamberlin JR, Lardi AB, McKeever LS et al (1999) Use of vascular sealing devices (VasoSeal and Perclose) versus assisted manual compression (Femostop) in transcatheter coronary interventions requiring abciximab (ReoPro). Catheter Cardiovasc Interv 47:143–147; discussion 148PubMedCrossRefGoogle Scholar
  8. 8.
    Gwechenberger M, Katzenschlager R, Heinz G, Gottsauner-Wolf M, Probst P (1997) Use of a collagen plug versus manual compression for sealing arterial puncture site after cardiac catheterization. Angiology 48:121–126PubMedCrossRefGoogle Scholar
  9. 9.
    Sanborn TA, Gibbs HH, Brinker JA, Knopf WD, Kosinski EJ, Roubin GS (1993) A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty. J Am Coll Cardiol 22:1273–1279PubMedCrossRefGoogle Scholar
  10. 10.
    Schickel SI, Adkisson P, Miracle V, Cronin SN (1999) Achieving femoral artery hemostasis after cardiac catheterization: a comparison of methods. Am J Crit Care 8:406–409PubMedGoogle Scholar
  11. 11.
    Schrader R, Steinbacher S, Burger W, Kadel C, Vallbracht C, Kaltenbach M (1992) Collagen application for sealing of arterial puncture sites in comparison to pressure dressing: a randomized trial. Cathet Cardiovasc Diagn 27:298–302PubMedCrossRefGoogle Scholar
  12. 12.
    Silber S, Bjorvik A, Muhling H, Rosch A (1998) Usefulness of collagen plugging with VasoSeal after PTCA as compared to manual compression with identical sheath dwell times. Cathet Cardiovasc Diagn 43:421–427PubMedCrossRefGoogle Scholar
  13. 13.
    Slaughter PM, Chetty R, Flintoft VF et al (1995) A single center randomized trial assessing use of a vascular hemostasis device vs. conventional manual compression following PTCA: what are the potential resource savings? Cathet Cardiovasc Diagn 34:210–214PubMedCrossRefGoogle Scholar
  14. 14.
    Nikolsky E, Mehran R, Halkin A et al (2004) Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol 44:1200–1209PubMedGoogle Scholar
  15. 15.
    Vaitkus PT (2004) A meta-analysis of percutaneous vascular closure devices after diagnostic catheterization and percutaneous coronary intervention. J Invasive Cardiol 16:243–246PubMedGoogle Scholar
  16. 16.
    Kussmaul WG 3rd, Buchbinder M, Whitlow PL et al (1995) Rapid arterial hemostasis and decreased access site complications after cardiac catheterization and angioplasty: results of a randomized trial of a novel hemostatic device. J Am Coll Cardiol 25:1685–1692PubMedCrossRefGoogle Scholar
  17. 17.
    Deuling JH, Vermeulen RP, Anthonio RA et al (2008) Closure of the femoral artery after cardiac catheterization: a comparison of Angio-Seal, StarClose, and manual compression. Catheter Cardiovasc Interv 71:518–523PubMedCrossRefGoogle Scholar
  18. 18.
    Martin JL, Pratsos A, Magargee E et al (2008) A randomized trial comparing compression, Perclose Proglide and Angio-Seal VIP for arterial closure following percutaneous coronary intervention: the CAP trial. Catheter Cardiovasc Interv 71:1–5PubMedCrossRefGoogle Scholar
  19. 19.
    Ward SR, Casale P, Raymond R, Kussmaul WG 3rd, Simpfendorfer C (1998) Efficacy and safety of a hemostatic puncture closure device with early ambulation after coronary angiography. Angio-Seal Investigators. Am J Cardiol 81:569–572PubMedCrossRefGoogle Scholar
  20. 20.
    Azmoon S, Pucillo AL, Aronow WS et al (2010) Vascular complications after percutaneous coronary intervention following hemostasis with the Mynx vascular closure device versus the AngioSeal vascular closure device. J Invasive Cardiol 22:175–178PubMedGoogle Scholar
  21. 21.
    Applegate RJ, Grabarczyk MA, Little WC et al (2002) Vascular closure devices in patients treated with anticoagulation and IIb/IIIa receptor inhibitors during percutaneous revascularization. J Am Coll Cardiol 40:78–83PubMedCrossRefGoogle Scholar
  22. 22.
    Cura FA, Kapadia SR, L’Allier PL et al (2000) Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockade. Am J Cardiol 86:780–782, A9PubMedCrossRefGoogle Scholar
  23. 23.
    Duffin DC, Muhlestein JB, Allisson SB et al (2001) Femoral arterial puncture management after percutaneous coronary procedures: a comparison of clinical outcomes and patient satisfaction between manual compression and two different vascular closure devices. J Invasive Cardiol 13:354–362PubMedGoogle Scholar
  24. 24.
    Applegate RJ, Rankin KM, Little WC, Kahl FR, Kutcher MA (2003) Restick following initial Angioseal use. Catheter Cardiovasc Interv 58:181–184PubMedCrossRefGoogle Scholar
  25. 25.
    Scheinert D, Sievert H, Turco MA et al (2007) The safety and efficacy of an extravascular, water-soluble sealant for vascular closure: initial clinical results for Mynx. Catheter Cardiovasc Interv 70:627–633PubMedCrossRefGoogle Scholar
  26. 26.
    Fields JD, Liu KC, Lee DS et al (2010) Femoral artery complications associated with the Mynx closure device. AJNR Am J Neuroradiol 31:1737–1740PubMedCrossRefGoogle Scholar
  27. 27.
    Noor S, Meyers S, Curl R (2010) Successful reduction of surgeries secondary to arterial access site complications: a retrospective review at a single center with an extravascular closure device. Vasc Endovascular Surg 44:345–349PubMedCrossRefGoogle Scholar
  28. 28.
    Islam MA, George AK, Norris M (2010) Popliteal artery embolization with the Mynx closure device. Catheter Cardiovasc Interv 75:35–37PubMedCrossRefGoogle Scholar
  29. 29.
    Garasic JM, Marin L, Anderson RD (2009) Acute evaluation of the Mynx vascular closure device during arterial re-puncture in an ovine model. J Invasive Cardiol 21:283–285PubMedGoogle Scholar
  30. 30.
    Bavry AA, Raymond RE, Bhatt DL et al (2008) Efficacy of a novel procedure sheath and closure device during diagnostic catheterization: the multicenter randomized clinical trial of the FISH device. J Invasive Cardiol 20:152–156PubMedGoogle Scholar
  31. 31.
    Wong SC, Bachinsky W, Cambier P et al (2009) A randomized comparison of a novel bioabsorbable vascular closure device versus manual compression in the achievement of hemostasis after percutaneous femoral procedures: the ECLIPSE (Ensure’s Vascular Closure Device Speeds Hemostasis Trial). JACC Cardiovasc Interv 2:785–793PubMedCrossRefGoogle Scholar
  32. 32.
    Carere RG, Webb JG, Ahmed T, Dodek AA (1996) Initial experience using Prostar: a new device for percutaneous suture-mediated closure of arterial puncture sites. Cathet Cardiovasc Diagn 37:367–372PubMedCrossRefGoogle Scholar
  33. 33.
    Assali AR, Sdringola S, Moustapha A et al (2003) Outcome of access site in patients treated with platelet glycoprotein IIb/IIIa inhibitors in the era of closure devices. Catheter Cardiovasc Interv 58:1–5PubMedCrossRefGoogle Scholar
  34. 34.
    Baim DS, Knopf WD, Hinohara T et al (2000) Suture-mediated closure of the femoral access site after cardiac catheterization: results of the suture to ambulate aNd discharge (STAND I and STAND II) trials. Am J Cardiol 85:864–869PubMedCrossRefGoogle Scholar
  35. 35.
    Nasu K, Tsuchikane E, Sumitsuji S (2003) Clinical effectiveness of the Prostar XL suture-mediated percutaneous vascular closure device following PCI: results of the Perclose AcceleRated Ambulation and DISchargE (PARADISE) Trial. J Invasive Cardiol 15:251–256PubMedGoogle Scholar
  36. 36.
    Starnes BW, O’Donnell SD, Gillespie DL et al (2003) Percutaneous arterial closure in peripheral vascular disease: a prospective randomized evaluation of the Perclose device. J Vasc Surg 38:263–271PubMedCrossRefGoogle Scholar
  37. 37.
    Tron C, Koning R, Eltchaninoff H et al (2003) A randomized comparison of a percutaneous suture device versus manual compression for femoral artery hemostasis after PTCA. J Interv Cardiol 16:217–221PubMedCrossRefGoogle Scholar
  38. 38.
    Gerckens U, Cattelaens N, Lampe EG, Grube E (1999) Management of arterial puncture site after catheterization procedures: evaluating a suture-mediated closure device. Am J Cardiol 83:1658–1663PubMedCrossRefGoogle Scholar
  39. 39.
    Noguchi T, Miyazaki S, Yasuda S et al (2000) A randomised controlled trial of Prostar Plus for haemostasis in patients after coronary angioplasty. Eur J Vasc Endovasc Surg 19:451–455PubMedCrossRefGoogle Scholar
  40. 40.
    Rickli H, Unterweger M, Sutsch G et al (2002) Comparison of costs and safety of a suture-mediated closure device with conventional manual compression after coronary artery interventions. Catheter Cardiovasc Interv 57:297–302PubMedCrossRefGoogle Scholar
  41. 41.
    Wetter DR, Rickli H, von Smekal A, Amann FW (2000) Early sheath removal after coronary artery interventions with use of a suture-mediated closure device: clinical outcome and results of Doppler US evaluation. J Vasc Interv Radiol 11:1033–1037PubMedCrossRefGoogle Scholar
  42. 42.
    Kornowski R, Brandes S, Teplitsky I et al (2002) Safety and efficacy of a 6 French perclose arterial suturing device following percutaneous coronary interventions: a pilot evaluation. J Invasive Cardiol 14:741–745PubMedGoogle Scholar
  43. 43.
    Carere RG, Webb JG, Buller CE et al (2000) Suture closure of femoral arterial puncture sites after coronary angioplasty followed by same-day discharge. Am Heart J 139:52–58PubMedCrossRefGoogle Scholar
  44. 44.
    Doyle BJ, Godfrey MJ, Lennon RJ et al (2007) Initial experience with the Cardiva Boomerang vascular closure device in diagnostic catheterization. Catheter Cardiovasc Interv 69:203–208PubMedCrossRefGoogle Scholar
  45. 45.
    Hermiller J, Simonton C, Hinohara T et al (2005) Clinical experience with a circumferential clip-based vascular closure device in diagnostic catheterization. J Invasive Cardiol 17:504–510PubMedGoogle Scholar
  46. 46.
    Hermiller JB, Simonton C, Hinohara T et al (2006) The StarClose Vascular Closure System: interventional results from the CLIP study. Catheter Cardiovasc Interv 68:677–683PubMedCrossRefGoogle Scholar
  47. 47.
    Branzan D, Sixt S, Rastan A et al (2009) Safety and efficacy of the StarClose vascular closure system using 7-F and 8-F sheath sizes: a consecutive single-center analysis. J Endovasc Surg 16:475–482Google Scholar
  48. 48.
    Veerina K (2011) Arterial closure is now the first step. Cath Lab Digest 19:32Google Scholar
  49. 49.
    Ahmed B, Piper WD, Malenka D et al (2009) Significantly improved vascular complications among women undergoing percutaneous coronary intervention: a report from the Northern New England Percutaneous Coronary Intervention Registry. Circ Cardiovasc Interv 2:423–429PubMedCrossRefGoogle Scholar
  50. 50.
    Applegate RJ, Sacrinty MT, Kutcher MA et al (2008) Trends in vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention via the femoral artery, 1998 to 2007. JACC Cardiovasc Interv 1:317–326PubMedCrossRefGoogle Scholar
  51. 51.
    Arora N, Matheny ME, Sepke C, Resnic FS (2007) A propensity analysis of the risk of vascular complications after cardiac catheterization procedures with the use of vascular closure devices. Am Heart J 153:606–611PubMedCrossRefGoogle Scholar
  52. 52.
    Sanborn TA, Ebrahimi R, Manoukian SV et al (2010) Impact of femoral vascular closure devices and antithrombotic therapy on access site bleeding in acute coronary syndromes: the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial. Circ Cardiovasc Interv 3:57–62PubMedCrossRefGoogle Scholar
  53. 53.
    Doyle BJ, Ting HH, Bell MR et al (2008) Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005. JACC Cardiovasc Interv 1:202–209PubMedCrossRefGoogle Scholar
  54. 54.
    Roe MT, Messenger JC, Weintraub WS et al (2010) Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. J Am Coll Cardiol 56:254–263PubMedCrossRefGoogle Scholar
  55. 55.
    Dauerman HL, Rao SV, Resnic FS, Applegate RJ (2011) Bleeding avoidance strategies. Consensus and controversy. J Am Coll Cardiol 58:1–10PubMedCrossRefGoogle Scholar
  56. 56.
    Tavris DR, Gallauresi BA, Lin B et al (2004) Risk of local adverse events following cardiac catheterization by hemostasis device use and gender. J Invasive Cardiol 16:459–464PubMedGoogle Scholar
  57. 57.
    Dangas G, Mehran R, Kokolis S et al (2001) Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. J Am Coll Cardiol 38:638–641PubMedCrossRefGoogle Scholar
  58. 58.
    Bangalore S, Arora N, Resnic FS (2009) Vascular closure device failure: frequency and implications: a propensity-matched analysis. Circ Cardiovasc Interv 2:549–556PubMedCrossRefGoogle Scholar
  59. 59.
    Farouque HM, Tremmel JA, Raissi Shabari F et al (2005) Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices. J Am Coll Cardiol 45:363–368PubMedCrossRefGoogle Scholar
  60. 60.
    Tiroch KA, Arora N, Matheny ME, Liu C, Lee TC, Resnic FS (2008) Risk predictors of retroperitoneal hemorrhage following percutaneous coronary intervention. Am J Cardiol 102:1473–1476PubMedCrossRefGoogle Scholar
  61. 61.
    Resnic FS, Blake GJ, Ohno-Machado L, Selwyn AP, Popma JJ, Rogers C (2001) Vascular closure devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein IIb-IIIa inhibitors. Am J Cardiol 88:493–496PubMedCrossRefGoogle Scholar
  62. 62.
    Warren BS, Warren SG, Miller SD (1999) Predictors of complications and learning curve using the Angio-Seal closure device following interventional and diagnostic catheterization. Catheter Cardiovasc Interv 48:162–166PubMedCrossRefGoogle Scholar
  63. 63.
    Balzer JO, Scheinert D, Diebold T, Haufe M, Vogl TJ, Biamino G (2001) Postinterventional transcutaneous suture of femoral artery access sites in patients with peripheral arterial occlusive disease: a study of 930 patients. Catheter Cardiovasc Interv 53:174–181PubMedCrossRefGoogle Scholar
  64. 64.
    Resnic FS, Wang TY, Arora N et al (2012) Quantifying the learning curve in the use of a novel vascular closure device: an analysis of the NCDR (National Cardiovascular Data Registry) CathPCI registry. JACC Cardiovasc Interv 5(1):82–89Google Scholar
  65. 65.
    Applegate RJ, Sacrinty M, Kutcher MA et al (2006) Vascular complications with newer generations of angioseal vascular closure devices. J Interv Cardiol 19:67–74PubMedCrossRefGoogle Scholar
  66. 66.
    Lasic Z, Mehran R, Dangas G et al (2004) Comparison of safety and efficacy between first and second generation of angio-seal closure devices in interventional patients. J Invasive Cardiol 16:356–358PubMedGoogle Scholar
  67. 67.
    Ben-Dor I, Looser P, Bernardo N et al (2011) Comparison of closure strategies after balloon aortic valvuloplasty: suture mediated versus collagen based versus manual. Catheter Cardiovasc Interv 78:119–124PubMedCrossRefGoogle Scholar
  68. 68.
    Feldman T (2000) Percutenous suture closure for management of large French size arterial and venous puncture. J Interv Cardiol 13:237–241CrossRefGoogle Scholar
  69. 69.
    Haas PC, Krajcer Z, Diethrich EB (1999) Closure of large percutaneous access sites using the Prostar XL Percutaneous Vascular Surgery device. J Endovasc Surg 6:168–170PubMedCrossRefGoogle Scholar
  70. 70.
    Howell M, Villareal R, Krajcer Z (2001) Percutaneous access and closure of femoral artery access sites associated with endoluminal repair of abdominal aortic aneurysms. J Endovasc Surg 8:68–74Google Scholar
  71. 71.
    Lee WA, Brown MP, Nelson PR, Huber TS, Seeger JM (2008) Midterm outcomes of femoral arteries after percutaneous endovascular aortic repair using the Preclose technique. J Vasc Surg 47:919–923PubMedCrossRefGoogle Scholar
  72. 72.
    Marchant D, Schwartz R, Chepurko L, Katz S (2000) Access site management after aortic valvuloplasty using a suture mediated closure device: clinical experience in 4 cases. J Invasive Cardiol 12:474–477PubMedGoogle Scholar
  73. 73.
    Michaels AD, Ports TA (2001) Use of a percutaneous arterial suture device (Perclose) in patients undergoing percutaneous balloon aortic valvuloplasty. Catheter Cardiovasc Interv 53:445–447PubMedCrossRefGoogle Scholar
  74. 74.
    Mylonas I, Sakata Y, Salinger M, Sanborn TA, Feldman T (2006) The use of percutaneous suture-mediated closure for the management of 14 French femoral venous access. J Invasive Cardiol 18:299–302PubMedGoogle Scholar
  75. 75.
    Solomon LW, Fusman B, Jolly N, Kim A, Feldman T (2001) Percutaneous suture closure for management of large French size arterial puncture in aortic valvuloplasty. J Invasive Cardiol 13:592–596PubMedGoogle Scholar
  76. 76.
    Teh LG, Sieunarine K, van Schie G et al (2001) Use of the percutaneous vascular surgery device for closure of femoral access sites during endovascular aneurysm repair: lessons from our experience. Eur J Vasc Endovasc Surg 22:418–423PubMedCrossRefGoogle Scholar
  77. 77.
    Traul DK, Clair DG, Gray B, O’Hara PJ, Ouriel K (2000) Percutaneous endovascular repair of infrarenal abdominal aortic aneurysms: a feasibility study. J Vasc Surg 32:770–776PubMedCrossRefGoogle Scholar
  78. 78.
    Morasch MD, Kibbe MR, Evans ME et al (2004) Percutaneous repair of abdominal aortic aneurysm. J Vasc Surg 40:12–16PubMedCrossRefGoogle Scholar
  79. 79.
    Torsello GB, Kasprzak B, Klenk E, Tessarek J, Osada N, Torsello GF (2003) Endovascular suture versus cutdown for endovascular aneurysm repair: a prospective randomized pilot study. J Vasc Surg 38:78–82PubMedCrossRefGoogle Scholar
  80. 80.
    Bhatt DL, Raymond RE, Feldman T et al (2002) Successful “pre-closure” of 7Fr and 8Fr femoral arteriotomies with a 6Fr suture-based device (the Multicenter Interventional Closer Registry). Am J Cardiol 89:777–779PubMedCrossRefGoogle Scholar
  81. 81.
    Nasu K, Tsuchikane E, Sumitsuji S, Tsuji T, Tamai H (2005) The safety and efficacy of “pre-closure” utilizing the Closer suture-mediated vascular closure device for achievement of hemostasis in patients following coronary interventions: results of the second Perclose Accelerated Ambulation and Discharge (PARADISE II) Trial. J Invasive Cardiol 17:30–33PubMedGoogle Scholar
  82. 82.
    Lee WA, Brown MP, Nelson PR, Huber TS (2007) Total percutaneous access for endovascular aortic aneurysm repair (“Preclose” technique). J Vasc Surg 45:1095–1101PubMedCrossRefGoogle Scholar
  83. 83.
    Izquierdo L, Criado E, Leiva L, Aguinaco A, Zotta R, Solares JI (2009) Triple-wire: a variation of the “Preclose” technique. Ann Vasc Surg 23:713–715PubMedCrossRefGoogle Scholar
  84. 84.
    Kahlert P, Eggebrecht H, Erbel R, Sack S (2008) A modified “preclosure” technique after percutaneous aortic valve replacement. Catheter Cardiovasc Interv 72:877–884PubMedCrossRefGoogle Scholar
  85. 85.
    Bowers BS, Head S, Brown D (2010) Temporary ­aortic occlusion to facilitate large-bore arterial closure. J Invasive Cardiol 22:503–504PubMedGoogle Scholar
  86. 86.
    Sharp AS, Michev I, Maisano F et al (2010) A new technique for vascular access management in transcatheter aortic valve implantation. Catheter Cardiovasc Interv 75:784–793PubMedCrossRefGoogle Scholar
  87. 87.
    Bui QT, Kolansky DM, Bannan A, Herrmann HC (2010) “Double wire” angio-seal closure technique after balloon aortic valvuloplasty. Catheter Cardiovasc Interv 75:488–492PubMedGoogle Scholar
  88. 88.
    Fallahi A, Kim M (2010) Initial experience of removal of 10-French sheaths using the 8-French Angio-Seal vascular closure device. J Invasive Cardiol 22:130–131PubMedGoogle Scholar
  89. 89.
    Korngold EC, Inglessis I, Garasic JM (2009) A novel technique for 14 French arteriotomy closure after percutaneous aortic valvuloplasty using two Mynx closure devices. J Interv Cardiol 22:179–183PubMedCrossRefGoogle Scholar
  90. 90.
    Katzenschlager R, Tischler R, Kalchhauser G, Panny M, Hirschl M (2009) Angio-Seal use in patients with peripheral arterial disease (ASPIRE). Angiology 60:536–538PubMedCrossRefGoogle Scholar
  91. 91.
    Rashid MN, Ahmed B, Straight F et al (2008) Extravascular closure for patients with high-risk femoral anatomy. J Invasive Cardiol 20:328–332PubMedGoogle Scholar
  92. 92.
    Gray BH, Miller R, Langan EM 3rd, Joels CS, Yasin Y, Kalbaugh CA (2009) The utility of the StarClose arterial closure device in patients with peripheral arterial disease. Ann Vasc Surg 23:341–344PubMedCrossRefGoogle Scholar
  93. 93.
    Dehghani P, Mohammad A, Marcuzzi D et al (2010) Efficacy and long-term safety of StarClose for hemostasis of arterial puncture sites distal to common femoral artery bifurcation after percutaneous coronary interventions. J Invasive Cardiol 22:505–510PubMedGoogle Scholar
  94. 94.
    Bangalore S, Vidi VD, Liu CB, Shah PB, Resnic FS (2011) Efficacy and safety of the nitinol clip-based vascular closure device (Starclose) for closure of common femoral arterial cannulation at or near the bifurcation: a propensity score-adjusted analysis. J Invasive Cardiol 23:194–199PubMedGoogle Scholar
  95. 95.
    Ellis SG, Bhatt D, Kapadia S, Lee D, Yen M, Whitlow PL (2006) Correlates and outcomes of retroperitoneal hemorrhage complicating percutaneous coronary intervention. Catheter Cardiovasc Interv 67:541–545PubMedCrossRefGoogle Scholar
  96. 96.
    Kulick DL, Rediker DE (1999) Use of the Perclose device in the brachial artery after coronary intervention. Catheter Cardiovasc Interv 46:111–112PubMedCrossRefGoogle Scholar
  97. 97.
    Gliech V, Dubel HP, Rutsch W (2001) Suture closure of the brachial artery access site post-coronary catheterization. J Invasive Cardiol 13:12–14PubMedGoogle Scholar
  98. 98.
    Kim A, Fusman B, Jolly N, Feldman T (2002) Percutaneous suture closure for brachial artery puncture. J Interv Cardiol 15:277–280PubMedCrossRefGoogle Scholar
  99. 99.
    Belenky A, Aranovich D, Greif F, Bachar G, Bartal G, Atar E (2007) Use of a collagen-based device for closure of low brachial artery punctures. Cardiovasc Intervent Radiol 30:273–275PubMedCrossRefGoogle Scholar
  100. 100.
    Bilecen D, Bongartz G, Ostheim-Dzerowycz W (2006) Off-label use of Angio-Seal vascular closure device for brachial artery puncture closure-deployment modification and initial results after transbrachial PTA. Eur J Vasc Endovasc Surg 31:431–433PubMedCrossRefGoogle Scholar
  101. 101.
    Lupattelli T, Clerissi J, Clerici G et al (2008) The efficacy and safety of closure of brachial access using the AngioSeal closure device: experience with 161 interventions in diabetic patients with critical limb ischemia. J Vasc Surg 47:782–788PubMedCrossRefGoogle Scholar
  102. 102.
    Puggioni A, Boesmans E, Deloose K, Peeters P, Bosiers M (2008) Use of StarClose for brachial artery closure after percutaneous endovascular interventions. Vascular 16:85–90PubMedCrossRefGoogle Scholar
  103. 103.
    Cirillo P, Petrillo G, D’Ascoli GL, Piscione F, Chiariello M (2010) Successful use of the Cardiva Boomerang vascular closure device to close a brachial artery puncture site after emergency PTCA. Heart Vessels 25:565–568PubMedCrossRefGoogle Scholar
  104. 104.
    Henry M, Amor M, Allaoui M, Tricoche O (1995) A new access site management tool: the Angio-Seal hemostatic puncture closure device. J Endovasc Surg 2:289–296PubMedCrossRefGoogle Scholar
  105. 105.
    Hoffmann K, Schott U, Erb M, Albes J, Claussen CD, Duda SH (1998) Remote suturing for percutaneous closure of popliteal artery access. Cathet Cardiovasc Diagn 43:477–482PubMedCrossRefGoogle Scholar
  106. 106.
    Noory E, Rastan A, Sixt S et al (2008) Arterial puncture closure using a clip device after transpopliteal retrograde approach for recanalization of the superficial femoral artery. J Endovasc Surg 15:310–314Google Scholar
  107. 107.
    Sakata Y, Syed Z, Salinger MH, Feldman T (2005) Percutaneous balloon aortic valvuloplasty: antegrade transseptal vs. conventional retrograde transarterial approach. Catheter Cardiovasc Interv 64:314–321PubMedCrossRefGoogle Scholar
  108. 108.
    Shaw JA, Dewire E, Nugent A, Eisenhauer AC (2004) Use of suture-mediated vascular closure devices for the management of femoral vein access after transcatheter procedures. Catheter Cardiovasc Interv 63:439–443PubMedCrossRefGoogle Scholar
  109. 109.
    Mahadevan VS, Jimeno S, Benson LN, McLaughlin PR, Horlick EM (2008) Pre-closure of femoral venous access sites used for large-sized sheath insertion with the Perclose device in adults undergoing cardiac intervention. Heart 94:571–572PubMedCrossRefGoogle Scholar
  110. 110.
    Coto HA (2002) Closure of the femoral vein puncture site after transcatheter procedures using Angio-Seal. Catheter Cardiovasc Interv 55:16–19PubMedCrossRefGoogle Scholar
  111. 111.
    Bovenschulte H, Chang DH, Michels G, Kochanek M, Liebig T, Bangard C (2011) Technical note: misplaced 13F-dialysis catheter in the subclavian artery – controlled removal with an undersized 8F-collagen closure system (AngioSeal(R)) and endovascular balloon fixation. RoFo 183:758–760PubMedCrossRefGoogle Scholar
  112. 112.
    Chemelli AP, Wiedermann F, Klocker J et al (2010) Endovascular management of inadvertent subclavian artery catheterization during subclavian vein cannulation. J Vasc Interv Radiol 21:470–476PubMedCrossRefGoogle Scholar
  113. 113.
    Devriendt A, Tran-Ngoc E, Gottignies P et al (2009) Ease of using a dedicated percutaneous closure device after inadvertent cannulation of the subclavian artery: case report. Case Report Med 2009:728629PubMedGoogle Scholar
  114. 114.
    Dowling K, Herr A, Siskin G, Sansivero GE, Stainken B (1999) Use of a collagen plug device to seal a subclavian artery puncture secondary to intraarterial dialysis catheter placement. J Vasc Interv Radiol 10:33–35PubMedCrossRefGoogle Scholar
  115. 115.
    Kirkwood ML, Wahlgren CM, Desai TR (2008) The use of arterial closure devices for incidental arterial injury. Vasc Endovascular Surg 42:471–476PubMedCrossRefGoogle Scholar
  116. 116.
    Micha JP, Goldstein BH, Lindsay SF et al (2007) Subclavian artery puncture repair with Angio-Seal deployment. Gynecol Oncol 104:761–763PubMedCrossRefGoogle Scholar
  117. 117.
    Nicholson T, Ettles D, Robinson G (2004) Managing inadvertent arterial catheterization during central venous access procedures. Cardiovasc Intervent Radiol 27:21–25PubMedGoogle Scholar
  118. 118.
    Railo M, Roth WD (2004) The use of a collagen-based puncture closure device in the subclavian artery after inadvertent introduction of an 11.5 French hemodialysis catheter. Cardiovasc Intervent Radiol 27:681–682PubMedCrossRefGoogle Scholar
  119. 119.
    Shetty SV, Kwolek CJ, Garasic JM (2007) Percutaneous closure after inadvertent subclavian artery cannulation. Catheter Cardiovasc Interv 69:1050–1052PubMedCrossRefGoogle Scholar
  120. 120.
    Berlet MH, Steffen D, Shaughness G, Hanner J (2001) Closure using a surgical closure device of inadvertent subclavian artery punctures during central venous catheter placement. Cardiovasc Intervent Radiol 24:122–124PubMedCrossRefGoogle Scholar
  121. 121.
    Fraizer MC, Chu WW, Gudjonsson T, Wolff MR (2003) Use of a percutaneous vascular suture device for closure of an inadvertent subclavian artery puncture. Catheter Cardiovasc Interv 59:369–371PubMedCrossRefGoogle Scholar
  122. 122.
    Meyhoefer J, Lehmann H, Minden HH, Butter C (2006) Closure of the subclavian artery puncture site with a percutaneous suture device after removal of an arterial pacemaker lead. Europace 8:1070–1072PubMedCrossRefGoogle Scholar
  123. 123.
    Wallace MJ, Ahrar K (2001) Percutaneous closure of a subclavian artery injury after inadvertent catheterization. J Vasc Interv Radiol 12:1227–1230PubMedCrossRefGoogle Scholar
  124. 124.
    Powers CJ, Zomorodi AR, Britz GW, Enterline DS, Miller MJ, Smith TP (2011) Endovascular management of inadvertent brachiocephalic arterial catheterization. J Neurosurg 114:146–152PubMedCrossRefGoogle Scholar
  125. 125.
    Tran V, Shiferson A, Hingorani AP et al (2009) Use of the StarClose device for closure of inadvertent subclavian artery punctures. Ann Vasc Surg 23:688.e11–688.e3CrossRefGoogle Scholar
  126. 126.
    Blanc R, Mounayer C, Piotin M, Sadik JC, Spelle L, Moret J (2002) Hemostatic closure device after carotid puncture for stent and coil placement in an intracranial aneurysm: technical note. AJNR Am J Neuroradiol 23:978–981PubMedGoogle Scholar
  127. 127.
    Hatfield MK, Zaleski GX, Kozlov D, Woo T, Gentile E, Sinnen J (2004) Angio-seal device used for hemostasis in the descending aorta. Am J Roentgenol 183:612–614Google Scholar
  128. 128.
    Brown SC, Boshoff DE, Rega F et al (2009) Transapical left ventricular access for difficult to reach interventional targets in the left heart. Catheter Cardiovasc Interv 74:137–142PubMedCrossRefGoogle Scholar
  129. 129.
    Murarka S, Heuser RR (2010) A novel method of ventricular closure following transapical access. Future Cardiol 6:881–887PubMedCrossRefGoogle Scholar
  130. 130.
    Barbash IM, Saikus CE, Ratnayaka K et al (2011) Limitations of closing percutaneous transthoracic ventricular access ports using a commercial collagen vascular closure device. Catheter Cardiovasc Interv 77:1079–1085PubMedCrossRefGoogle Scholar
  131. 131.
    Resnic FS, Arora N, Matheny M, Reynolds MR (2007) A cost-minimization analysis of the angio-seal vascular closure device following percutaneous coronary intervention. Am J Cardiol 99:766–770PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  1. 1.Brigham and Women’s Hospital, Harvard Medical SchoolBostonUSA
  2. 2.Brigham and Women’s Hospital, Harvard Medical SchoolBostonUSA
  3. 3.Cardiac Catheterization LaboratoryBrigham and Women’s Hospital, Harvard Medical SchoolBostonUSA

Personalised recommendations